Protagonist Therapeutics Inc (PTGX)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Total assets | US$ in thousands | 744,725 | 357,951 | 247,928 | 347,695 | 324,468 |
| Total asset turnover | 0.58 | 0.17 | 0.11 | 0.08 | 0.09 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $434,433K ÷ $744,725K
= 0.58
Protagonist Therapeutics Inc's total asset turnover has displayed varying trends over the past five years. In 2020 and 2021, the company's total asset turnover ratio was relatively low at 0.09 and 0.08, respectively, indicating that the company generated $0.09 and $0.08 in revenue for every $1 of total assets during those years.
However, there was a significant improvement in 2022 as the total asset turnover ratio increased to 0.11, suggesting that the company became more efficient in generating revenue from its assets. This trend continued in 2023, with a further increase to 0.17, indicating a more effective utilization of assets to generate sales.
Notably, in 2024, Protagonist Therapeutics Inc experienced a substantial surge in total asset turnover to 0.58. This sharp increase indicates a significant enhancement in the company's asset efficiency, implying that the company generated $0.58 in revenue for every $1 of total assets, reflecting a notable improvement in operational performance and asset utilization efficiency.
Peer comparison
Dec 31, 2024